| Arturo Salgado, MD | |
|
13652 Cantara St, Panorama City, CA 91402-5423 | |
| (818) 375-2000 | |
| Not Available |
| Full Name | Arturo Salgado |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Location | 13652 Cantara St, Panorama City, California |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1306913306 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | G79645 (California) | Primary |
| Entity Name | Southern California Permanente Medical Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1770515280 PECOS PAC ID: 6002729175 Enrollment ID: O20031110000678 |
News Archive
Today, Florida House Joint Resolution 37—a constitutional amendment protecting a patient's right to pay directly for medical care, and prohibiting penalties for failing to purchase health insurance—passed the critical Rules & Calendar Council and is now slated for consideration by the full Florida House.
Stateline examines the difficulty for many working families to buy insurance while KHN spends time at a California hospital to survey how some without insurance try to afford care. Other news coverage on health law outreach and enrollment looks at narrow networks in some plans and an effort in Connecticut to attract consumers.
Janssen Pharmaceuticals, Inc.announced today that it has entered into an exclusive license agreement with Vertex Pharmaceuticals for the worldwide development, manufacturing and commercialization of VX-787, a novel medicine in Phase II development for the treatment of influenza A.
The Health Protection Agency today publishes its first national report on the current status of the UK's universal vaccine programmes, which protect children against a range of childhood diseases including measles, mumps, rubella and meningitis.
Seattle Genetics, Inc. and Agensys, Inc., an affiliate of Tokyo-based Astellas Pharma Inc., today reported preclinical data with ASG-5ME, an antibody-drug conjugate (ADC) that is being co-developed by both companies for the treatment of solid tumors. In models of human prostate and pancreatic cancer, ASG-5ME was found to have potent and long lasting antitumor activity. The findings were presented at the 101st Annual Meeting of the American Association for Cancer Research (AACR) being held in Washington, D.C.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Arturo Salgado, MD 13652 Cantara St, Panorama City, CA 91402-5423 Ph: (818) 375-2000 | Arturo Salgado, MD 13652 Cantara St, Panorama City, CA 91402-5423 Ph: (818) 375-2000 |
News Archive
Today, Florida House Joint Resolution 37—a constitutional amendment protecting a patient's right to pay directly for medical care, and prohibiting penalties for failing to purchase health insurance—passed the critical Rules & Calendar Council and is now slated for consideration by the full Florida House.
Stateline examines the difficulty for many working families to buy insurance while KHN spends time at a California hospital to survey how some without insurance try to afford care. Other news coverage on health law outreach and enrollment looks at narrow networks in some plans and an effort in Connecticut to attract consumers.
Janssen Pharmaceuticals, Inc.announced today that it has entered into an exclusive license agreement with Vertex Pharmaceuticals for the worldwide development, manufacturing and commercialization of VX-787, a novel medicine in Phase II development for the treatment of influenza A.
The Health Protection Agency today publishes its first national report on the current status of the UK's universal vaccine programmes, which protect children against a range of childhood diseases including measles, mumps, rubella and meningitis.
Seattle Genetics, Inc. and Agensys, Inc., an affiliate of Tokyo-based Astellas Pharma Inc., today reported preclinical data with ASG-5ME, an antibody-drug conjugate (ADC) that is being co-developed by both companies for the treatment of solid tumors. In models of human prostate and pancreatic cancer, ASG-5ME was found to have potent and long lasting antitumor activity. The findings were presented at the 101st Annual Meeting of the American Association for Cancer Research (AACR) being held in Washington, D.C.
› Verified 9 days ago
Yumi Christine Ishihara, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 13651 Willard St, Panorama City, CA 91402 Phone: 818-375-2000 | |
Karen Shih Tan, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 13652 Cantara St, Emergency Department, Panorama City, CA 91402 Phone: 818-375-2013 | |
William W. Jou, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 13652 Cantara St, Panorama City, CA 91402 Phone: 818-375-2000 | |
Christine A. Bloom, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 13652 Cantara St, Panorama City, CA 91402 Phone: 818-375-2000 | |
Seth Jin Kutik, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 13651 Willard St, Emergency Medicine Department, Panorama City, CA 91402 Phone: 818-375-2000 | |
Dr. Timothy Ting-han Chang, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 13652 Cantara St, Panorama City, CA 91402 Phone: 818-375-4231 |